查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496006

全球骨水泥市场：2024-2029 年预测

Global Bone Cement Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 160 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

骨水泥市场预计在预测期内将以 5.67% 的复合年增长率成长，从 2022 年的 17.8 亿美元增至 2029 年的 26.19 亿美元。

骨水泥是指将聚甲基丙烯酸甲酯（PMMA）、磷酸钙、玻璃聚链烯酸酯等粉末与液态单体混合而成的合成生物材料。这种水泥具有超强的黏合性能，可应用于髋关节、膝关节和关节关节重建等整形外科手术。自癒特性和作为人工关节的功能正在推动医疗领域对骨水泥的需求。

灾难性伤害、事故、整形外科手术生产者数量的增加，加上人口老化的加剧，正在为骨水泥市场创造进一步的成长机会。例如，根据美国劳工统计局提供的资料，2019年美国发生的致命工伤事故为5,333起，比2015年发生的4,836起大幅增加10.3%。

随着此类死亡人数的增加，骨水泥在治疗所有骨骼相关损伤中的使用范围也在扩大，从而推动了预测期内骨水泥市场的需求和成长。市场区隔分为聚甲基丙烯酸甲酯、磷酸钙、玻璃聚链烯酸酯。在骨水泥市场的预测期内，聚甲基丙烯酸甲酯领域预计将出现相对较高的成长率。

聚甲基丙烯酸甲酯机械强度高、毒性低、自硬化性能好，非常适合人工关节的固定。因此，PMMA骨水泥可作为骨骼和植入之间的空间填充物，改善植入的固定。聚丙烯酸甲酯骨水泥的高性能，加上其成本效益和高耐用性，预计将推动未来人工关节手术的需求，从而带动预测期内同一细分市场的增长以及整体市场的增长。你。

市场驱动因素：

  • 整形外科手术数量的快速增加正在推动骨水泥市场的需求。

骨水泥在整形外科手术中具有很高的适用性，用人造骨取代受损的骨部分，并使用骨水泥将人造骨固定指定。由于关节和骨骼疼痛、骨关节炎和交通事故的增加，尤其是老年人的整形外科手术数量每年都在显着增加。例如，根据美国整形外科学会的年度报告，2021年美国进行了240万例膝关节和关节重建，2021年美国总共置换术。比，增加了18.3%。

此外，根据澳洲整形外科协会国家关节置换手术登记处2022年年度报告，2021年澳洲报告的关节重建总数为185万例，其中膝关节关节重建手术占最大份额，为68,466例，其次是髋关节置换手术。置换术为 52,787 例。与2020年关节关节重建手术总数相比，2021年关节关节重建手术的整体成长率为7.6%。

随着整形外科手术数量的增加，作为骨间隙填充材的骨水泥的需求和消耗预计也会增加，这为预测期内骨水泥市场的成长带来了积极的前景。然而，骨水泥製备的巨大成本加上植入併发症将阻碍预测期内全球水泥市场的成长。

  • 关节和骨损伤发生率的增加可能会推动骨水泥市场的发展。

骨水泥市场是由经常需要整形外科干预的运动伤害的增加所推动的。骨水泥，也称为聚甲基丙烯酸甲酯，用于关节重建手术中以将植入固定到骨头上。全世界越来越多地参与体育运动和身体活动，导致与运动相关的伤害增加，特别是那些影响骨骼和关节的伤害。

骨水泥技术的进步，例如用于预防感染疾病和改善生物相容性的抗生素水泥，使其成为各种整形外科应用的首选。随着人口老化和人们越来越重视保持积极的生活方式，退化性关节疾病和运动相关损伤的盛行率增加，从而增加了对整形外科手术的需求。

使用骨水泥的整形外科手术来支持復健并允许个人恢復活动能力和功能。受运动伤害影响，骨水泥市场预计将继续扩大。

市场限制因素：

  • 高成本和严格的临床资料要求可能会限制市场成长。

骨水泥开发是一个成本高且耗时的过程，需要大量的研发投资。 FDA 对外科整形外科水泥的严格核准程序推迟了新产品的发布。 FDA 正在要求更多有关安全性和有效性的临床资料，这将需要进一步的研发投资。儘管有先进的水泥，但仍寻求具有必要临床资料的具有成本效益的选择，这影响了市场的生存。骨钉和整形外科钉等替代品也阻碍了先进骨水泥的普及。

主要进展

  • 2022 年 8 月 - Graftys 与 Arthrex 续签了先进合成骨移植材料的多年供应协议。该协议提供了利用尖端骨科技术的多个新商机。 Graftys是一家创新主导的医疗技术公司，从事合成骨生物材料的开发和製造。该公司的目标是成为骨生医材料设计、製造和分销领域的领导企业，其产品组合基于临床证据以及与欧洲领先学术研究机构的合作。
  • 2022 年 6 月 - 马来西亚 KPower Bhd 透过其子公司 Granulab (M) Sdn Bhd 推出了 Prosteomax，该国首款获得清真认证的合成骨水泥。磷酸钙水泥已获得七个国家的CE认证和马来西亚伊斯兰发展局（Jakim）的清真认证。它还在马来西亚医疗设备管理局註册用于整形外科、颅骨、牙科和颚颜面应用。 Granulab 也生产 GranuMas，这是一种颗粒状合成骨移植物，在马来西亚是清真产品。该公司正在与卫生福利部洽谈成为马来西亚的医院营运公司。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章全球骨水泥市场：依类型

  • 介绍
  • 聚甲基丙烯酸甲酯
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 磷酸钙
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 玻璃聚链烯酸酯
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第六章全球骨水泥市场：依黏度分类

  • 介绍
  • 低黏度
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 中等黏度
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 高黏度
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第七章全球骨水泥市场：依抗生素类型

  • 介绍
  • 庆大霉素
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 妥布霉素
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • Cefuroxime
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第八章全球骨水泥市场：依应用分类

  • 介绍
  • 人工关节重建
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 椎体成形术
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 椎体成形术
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 其他的
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第九章全球骨水泥市场：依最终用户分类

  • 介绍
  • 医院/诊所
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 门诊手术中心
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第十章全球骨水泥市场：按地区

  • 介绍
  • 北美洲
    • 按类型
    • 按黏度
    • 依抗生素类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 南美洲
    • 按类型
    • 按黏度
    • 依抗生素类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 欧洲
    • 按类型
    • 按黏度
    • 依抗生素类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 中东/非洲
    • 按类型
    • 按黏度
    • 依抗生素类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 亚太地区
    • 按类型
    • 按黏度
    • 依抗生素类型
    • 按用途
    • 按最终用户
    • 按国家/地区

第十一章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十二章 公司简介

  • DePuy Synthesis（Part of Johnson & Johnson）
  • Stryker
  • Zimmer Biomet
  • Tecres SpA
  • Synimed Synergie Ingenierie Medicale SARL
  • Olympus Corporation
  • Heraeus holdings
  • Teknimed
  • Exactech Inc.
  • DJO, LLC
简介目录
Product Code: KSI061611894

The global bone cement market is expected to grow at a CAGR of 5.67% over the forecast period to reach US$2.619 billion by 2029 from US$1.780 billion in 2022.

Bone cement refers to a synthetic biomaterial obtained from mixing polymethyl methacrylate (PMMA), calcium phosphate, or glass polyalkenoate powder with a liquid monomer. The cement has a super gluing feature owing to which it has high applicability in orthopedical surgical procedures such as hip, knee, and joint replacement. The self-healing nature and the ability to work as artificial joints are what drives the demand for bone cement in the medical field.

The growing prevalence of fatal injuries, accidents, and orthopedical surgical producers, coupled with the rising old age population, has provided more growth opportunities to the global bone cement market. For instance, according to the data provided by the US Bureau of Labor Statistics, in 2019, the number of fatal work injuries that occurred in the US stood at 5,333, which showed a significant increase of 10.3% in comparison to the 4,836 injuries that occurred in 2015.

With such an increase in fatal injuries, the scope of bone cement usage for the treatment of any bone-related injury also increases, thereby boosting the market demand and growth of the global bone cement market during the forecast period. The global bone cement market is segmented into polymethyl methacrylate, calcium phosphate, and glass polyalkenoate. The polymethyl methacrylate segment is expected to grow at a relatively higher rate during the forecast period of the global bone cement market.

Polymethyl Methacrylate has rich mechanical strength, minimal toxicity, and provides improved self-curing properties owing to which it has high applicability during joint prostheses fixation. Hence, acting as a space filler between the bone and the implant, PMMA bone cement improves the fixation of the implant. The high-performance features of polymethyl acrylate bone cement, coupled with its cost-effectiveness and high durability, are expected to increase its demand for joint prostheses surgeries in the future, thereby boosting its segment growth as well as the overall global bone cement market growth during the forecast period.

Market Drivers:

  • The rapid increase in the number of orthopedic surgeries is driving the market demand for bone cement.

Bone cement has high applicability in orthopedical surgical procedures where the damaged bone part is replaced with a prosthesis, and to hold the prosthesis in its place, bone cement is used. The number of orthopedical surgical procedures has shown a significant increase over the years owing to the growing number of joint & bone pain in people, especially in old age, coupled with growing cases of osteoarthritis and road accidents. For instance, according to the annual report by the American Academy of Orthopedic Surgeons, in 2021, the number of knee and hip bone replacement surgeries stood at 2.4 million in the US, which showed an increase of 18.3% in comparison to the number of surgical procedures conducted in 2020.

Furthermore, according to the 2022 annual report of the Australia Orthopaedic Association National Joint Replacement Surgery Registry, in 2021, the total number of joint replacement surgeries reported in 2021 Australia stood at 1.85 million, of which knee replacement held the largest share of 68,466, followed by hips replacement with 52,787. The overall increase in joint replacement surgeries in 2021 was 7.6% in comparison to 2020's joint replacement surgical volume.

With such an increase in the number of orthopedic surgical procedures, the demand and consumption of bone cement to act as a gap filler in bones are also anticipated to increase, thereby providing a positive outlook for the global bone cement market growth during the forecast period. However, the extensive cost incurred in preparing bone cement coupled with implant complications is projected to hamper the global cement market growth during the forecast period.

  • Increasing incidence of joints and bone injuries would propel the bone cement market.

The bone cement market is driven by the increasing number of sports injuries, which often require orthopedic interventions. Bone cement, also known as polymethylmethacrylate, is used in joint replacement procedures to anchor implants to the bone. The global increase in sports participation and physical activities has led to an increase in sports-related injuries, particularly those affecting bones and joints.

Advancements in bone cement technology, such as antibiotic-loaded cement to prevent infections or improved biocompatibility, make it a preferred choice in various orthopedic applications. The aging population and increased emphasis on maintaining an active lifestyle result in a higher prevalence of degenerative joint conditions and sports-related injuries, driving the demand for orthopedic procedures.

Orthopedic procedures involving bone cement can support rehabilitation, allowing individuals to regain mobility and function. The global bone cement market expansion is expected to continue due to the impact of sports injuries.

Market Restraints:

  • High expenses and stringent clinical data requirements could restrain the market growth.

The development of bone cement is a costly and time-consuming process that requires significant R&D investments. The FDA's stringent approval process for surgical orthopedic cement delays new product releases. The FDA demands more clinical data for safety and efficacy, resulting in additional R&D investments. Despite advanced cements, there is still a need for cost-effective options with required clinical data, affecting market survival. Alternatives like bone staples and orthopedic pins also hinder the uptake of advanced bone cement.

Key Developments:

  • August 2022- Graftys renewed its multi-year supply agreement with Arthrex for advanced synthetic bone graft materials. The agreement provided multiple new business opportunities using state-of-the-art orthobiologic technology. Graftys, an innovation-driven medtech company, is committed to the development and manufacturing of synthetic bone biomaterials. The company aims to become a major player in the design, manufacturing, and distribution of bone biomaterials, with a portfolio built on clinical evidence and partnerships with leading academic research institutions in Europe.
  • June 2022- Malaysia's KPower Bhd introduced Prosteomax, the country's first halal-certified synthetic bone cement, through its subsidiary Granulab (M) Sdn Bhd. The calcium phosphate-based cement received CE certification in seven countries and halal certification from the Islamic Development Department Malaysia (Jakim). It is registered with the Malaysian Medical Device Authority for orthopaedics, cranial, dental, and maxillofacial applications. Granulab also produces granular synthetic bone grafts, GranuMas, a halal product in Malaysia. The company is in talks with the Health Ministry to become a hospital operator in Malaysia.

Market Segmentation:

By Type

  • Polymethyl Methacrylate
  • Calcium Phosphate
  • Glass Polyalkenoate

By Viscosity

  • Low
  • Medium
  • High

By Antibiotics Type

  • Gentamicin
  • Tobramycin
  • Cefuroxime

By Application

  • Arthroplasty
  • Kyphoplasty
  • Vertebroplasty
  • Others

By End-User

  • Hospitals & Clinics
  • Ambulatory Surgical Center

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • United Arab Emirates
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL BONE CEMENT MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Polymethyl Methacrylate
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Calcium Phosphate
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Glass Polyalkenoate
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness

6. GLOBAL BONE CEMENT MARKET BY VISCOSITY

  • 6.1. Introduction
  • 6.2. Low
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Medium
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. High
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness

7. GLOBAL BONE CEMENT MARKET BY ANTIBIOTICS TYPE

  • 7.1. Introduction
  • 7.2. Gentamicin
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Tobramycin
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Cefuroxime
    • 7.4.1. Market Opportunities and Trends
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness

8. GLOBAL BONE CEMENT MARKET BY APPLICATION

  • 8.1. Introduction
  • 8.2. Arthroplasty
    • 8.2.1. Market Opportunities and Trends
    • 8.2.2. Growth Prospects
    • 8.2.3. Geographic Lucrativeness
  • 8.3. Kyphoplasty
    • 8.3.1. Market Opportunities and Trends
    • 8.3.2. Growth Prospects
    • 8.3.3. Geographic Lucrativeness
  • 8.4. Vertebroplasty
    • 8.4.1. Market Opportunities and Trends
    • 8.4.2. Growth Prospects
    • 8.4.3. Geographic Lucrativeness
  • 8.5. Others
    • 8.5.1. Market Opportunities and Trends
    • 8.5.2. Growth Prospects
    • 8.5.3. Geographic Lucrativeness

9. GLOBAL BONE CEMENT MARKET BY END-USER

  • 9.1. Introduction
  • 9.2. Hospitals & Clinics
    • 9.2.1. Market Opportunities and Trends
    • 9.2.2. Growth Prospects
    • 9.2.3. Geographic Lucrativeness
  • 9.3. Ambulatory Surgical Center
    • 9.3.1. Market Opportunities and Trends
    • 9.3.2. Growth Prospects
    • 9.3.3. Geographic Lucrativeness

10. GLOBAL BONE CEMENT MARKET BY GEOGRAPHY

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. By Type
    • 10.2.2. By Viscosity
    • 10.2.3. By Antibiotics Type
    • 10.2.4. By Application
    • 10.2.5. By End-User
    • 10.2.6. By Country
      • 10.2.6.1. USA
        • 10.2.6.1.1. Market Opportunities and Trends
        • 10.2.6.1.2. Growth Prospects
      • 10.2.6.2. Canada
        • 10.2.6.2.1. Market Opportunities and Trends
        • 10.2.6.2.2. Growth Prospects
      • 10.2.6.3. Mexico
        • 10.2.6.3.1. Market Opportunities and Trends
        • 10.2.6.3.2. Growth Prospects
  • 10.3. South America
    • 10.3.1. By Type
    • 10.3.2. By Viscosity
    • 10.3.3. By Antibiotics Type
    • 10.3.4. By Application
    • 10.3.5. By End-User
    • 10.3.6. By Country
      • 10.3.6.1. Brazil
        • 10.3.6.1.1. Market Opportunities and Trends
        • 10.3.6.1.2. Growth Prospects
      • 10.3.6.2. Argentina
        • 10.3.6.2.1. Market Opportunities and Trends
        • 10.3.6.2.2. Growth Prospects
      • 10.3.6.3. Others
        • 10.3.6.3.1. Market Opportunities and Trends
        • 10.3.6.3.2. Growth Prospects
  • 10.4. Europe
    • 10.4.1. By Type
    • 10.4.2. By Viscosity
    • 10.4.3. By Antibiotics Type
    • 10.4.4. By Application
    • 10.4.5. By End-User
    • 10.4.6. By Country
      • 10.4.6.1. Germany
        • 10.4.6.1.1. Market Opportunities and Trends
        • 10.4.6.1.2. Growth Prospects
      • 10.4.6.2. France
        • 10.4.6.2.1. Market Opportunities and Trends
        • 10.4.6.2.2. Growth Prospects
      • 10.4.6.3. United Kingdom
        • 10.4.6.3.1. Market Opportunities and Trends
        • 10.4.6.3.2. Growth Prospects
      • 10.4.6.4. Italy
        • 10.4.6.4.1. Market Opportunities and Trends
        • 10.4.6.4.2. Growth Prospects
      • 10.4.6.5. Spain
        • 10.4.6.5.1. Market Opportunities and Trends
        • 10.4.6.5.2. Growth Prospects
      • 10.4.6.6. Others
        • 10.4.6.6.1. Market Opportunities and Trends
        • 10.4.6.6.2. Growth Prospects
  • 10.5. Middle East and Africa
    • 10.5.1. By Type
    • 10.5.2. By Viscosity
    • 10.5.3. By Antibiotics Type
    • 10.5.4. By Application
    • 10.5.5. By End-User
    • 10.5.6. By Country
      • 10.5.6.1. Saudi Arabia
        • 10.5.6.1.1. Market Opportunities and Trends
        • 10.5.6.1.2. Growth Prospects
      • 10.5.6.2. Israel
        • 10.5.6.2.1. Market Opportunities and Trends
        • 10.5.6.2.2. Growth Prospects
      • 10.5.6.3. United Arab Emirates
        • 10.5.6.3.1. Market Opportunities and Trends
        • 10.5.6.3.2. Growth Prospects
        • 10.5.6.3.3.
      • 10.5.6.4. Others
        • 10.5.6.4.1. Market Opportunities and Trends
        • 10.5.6.4.2. Growth Prospects
  • 10.6. Asia Pacific
    • 10.6.1. By Type
    • 10.6.2. By Viscosity
    • 10.6.3. By Antibiotics Type
    • 10.6.4. By Application
    • 10.6.5. By End-User
    • 10.6.6. By Country
      • 10.6.6.1. China
        • 10.6.6.1.1. Market Opportunities and Trends
        • 10.6.6.1.2. Growth Prospects
      • 10.6.6.2. Japan
        • 10.6.6.2.1. Market Opportunities and Trends
        • 10.6.6.2.2. Growth Prospects
      • 10.6.6.3. South Korea
        • 10.6.6.3.1. Market Opportunities and Trends
        • 10.6.6.3.2. Growth Prospects
      • 10.6.6.4. India
        • 10.6.6.4.1. Market Opportunities and Trends
        • 10.6.6.4.2. Growth Prospects
      • 10.6.6.5. Australia
        • 10.6.6.5.1. Market Opportunities and Trends
        • 10.6.6.5.2. Growth Prospects
      • 10.6.6.6. Indonesia
        • 10.6.6.6.1. Market Opportunities and Trends
        • 10.6.6.6.2. Growth Prospects
      • 10.6.6.7. Thailand
        • 10.6.6.7.1. Market Opportunities and Trends
        • 10.6.6.7.2. Growth Prospects
      • 10.6.6.8. Taiwan
        • 10.6.6.8.1. Market Opportunities and Trends
        • 10.6.6.8.2. Growth Prospects
      • 10.6.6.9. Others
        • 10.6.6.9.1. Market Opportunities and Trends
        • 10.6.6.9.2. Growth Prospects

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 11.1. Major Players and Strategy Analysis
  • 11.2. Market Share Analysis
  • 11.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 11.4. Competitive Dashboard

12. COMPANY PROFILES

  • 12.1. DePuy Synthesis (Part of Johnson & Johnson)
  • 12.2. Stryker
  • 12.3. Zimmer Biomet
  • 12.4. Tecres SpA
  • 12.5. Synimed Synergie Ingenierie Medicale S.A.R.L
  • 12.6. Olympus Corporation
  • 12.7. Heraeus holdings
  • 12.8. Teknimed
  • 12.9. Exactech Inc.
  • 12.10. DJO, LLC